Enorama Pharma AB Net Asset Quality Index
Enorama Pharma AB net asset quality index. Enorama Pharma AB (ERMA) has a Net Asset Quality Index of -725.6% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr6.95 Million minus total liabilities of Skr57.39 Million yields net assets of Skr-50.44 Million. A higher index indicates a stronger, lower-leverage balance sheet. See ERMA net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Enorama Pharma AB (2014–2025)
Net asset quality index of Enorama Pharma AB from 2014 to 2025. This chart shows how Enorama Pharma AB's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the index stands at -725.6%, representing net assets of Skr-50.44 Million against total assets of Skr6.95 Million SEK. Check Enorama Pharma AB strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Enorama Pharma AB Net Asset Quality Index by Year (2014–2025)
Enorama Pharma AB net asset quality index by year from 2014 to 2025. The table below presents the year-by-year Net Asset Quality Index for Enorama Pharma AB from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Enorama Pharma AB worth.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -283.8% | Skr-23.45 Million | Skr8.26 Million | Skr31.71 Million | ▼ -332.9 pp |
| 2024 | 49.1% | Skr7.80 Million | Skr15.89 Million | Skr8.09 Million | ▼ -7.7 pp |
| 2023 | 56.8% | Skr19.54 Million | Skr34.38 Million | Skr14.85 Million | ▼ -7.9 pp |
| 2022 | 64.7% | Skr31.52 Million | Skr48.72 Million | Skr17.20 Million | ▲ +22.8 pp |
| 2021 | 41.9% | Skr21.35 Million | Skr50.93 Million | Skr29.58 Million | ▲ +37.6 pp |
| 2020 | 4.3% | Skr1.78 Million | Skr40.91 Million | Skr39.13 Million | ▼ -12.5 pp |
| 2019 | 16.9% | Skr7.18 Million | Skr42.58 Million | Skr35.40 Million | ▼ -27.0 pp |
| 2018 | 43.8% | Skr17.02 Million | Skr38.83 Million | Skr21.81 Million | ▼ -3.7 pp |
| 2017 | 47.5% | Skr7.36 Million | Skr15.49 Million | Skr8.13 Million | ▼ -19.1 pp |
| 2016 | 66.6% | Skr9.08 Million | Skr13.63 Million | Skr4.55 Million | ▼ -4.5 pp |
| 2015 | 71.2% | Skr6.52 Million | Skr9.17 Million | Skr2.64 Million | ▼ -0.8 pp |
| 2014 | 72.0% | Skr2.66 Million | Skr3.69 Million | Skr1.03 Million | — |